← Back to Remus Pharmaceuticals Ltd Overview

📊Financials 📈PE Ratio 🥧Shareholding 💰Dividend 📋Quarterly ⚖️Balance Sheet 💹P&L 🌊Cash Flow

REMUSPharmaceuticals

Remus Pharmaceuticals Ltd — Financial Ratios & Key Metrics

₹627.90

-9.48%

P/E Ratio25.09xIndustry: 31.77x

ROE14.00%Return on equity

ROCE19.64%Return on capital

Debt/Equity0.05Low debt

💎

Valuation & Profitability

P/E Ratio

25.09x

Industry Average P/E

31.77x

Dividend Yield

0.14%

Market Cap

₹840.73 (Cr)

Sales Growth 5Y

N/A

Profit Growth 5Y

N/A

EPS Growth 5Y

N/A

OPM 5Y Avg

N/A

📉

Price Returns

1 Month

-0.92%

3 Months

-21.15%

6 Months

-28.36%

1 Year

-47.36%

52W Low

₹601

Current

₹628

52W High

₹2279

2% of 52-week range — Near lows

🔬

Technical Indicators

Neutral

Momentum is balanced — neither overbought nor oversold.

SMA 50

₹705

▼ Price below SMA 50 — Bearish

SMA 200

₹1232

▼ Long-term downtrend

Volume Signal

286% of avg

Above average volume — strong conviction behind price move

Technical indicators are for educational purposes only. Not investment advice.

More on Remus Pharmaceuticals Ltd

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.